FHTX Deferred Revenue
Foghorn Therapeutics Inc · Deferred Revenue
FHTX Deferred Revenue
Latest reported$36.59Mperiod ending
FHTX Quarterly Deferred Revenue ($0.00 → $36.59M)
Quarterly deferred revenue
High-resolution chart · PNG
FHTX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 36,593,000 | |
| 52,300,000 | |
| 43,192,000 | |
| 65,299,000 | |
| 59,724,000 | |
| 51,672,000 | |
| 45,606,000 | |
| 33,384,000 | |
| 31,231,000 | |
| 31,501,000 | |
| 34,550,000 | |
| 28,345,000 | |
| 33,896,000 | |
| 33,331,000 | |
| 32,820,000 | |
| 33,161,000 | |
| 30,565,000 | |
| 30,059,000 | |
| 28,317,000 | |
| 1,278,000 | |
| 910,000 | |
| 2,407,000 | |
| 2,024,000 | |
| 1,696,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |